Kindeva Welcomes Mike Ratigan to the Leadership Team

Woodbury – January 17, 2022 – Effective January 3, 2022, Mike Ratigan joined the Kindeva team as the Vice President, Business Development and Marketing, Microneedles. Mike comes to Kindeva with a career spent in drug delivery, with a particular focus on injectable delivery and devices. Most recently, he was Chief Commercial Officer at Eitan Medical, a private company developing novel wearable drug delivery platforms. Previously, he led global sales & marketing efforts at Phillips-Medisize, an industry leader in contract development and manufacturing focused on drug delivery technology applications. He has also held commercial leadership roles at Becton Dickinson, Unilife, and Stryker. His commercial track record approaches $1B in total development, partnership and manufacturing agreements with global biopharmaceutical companies, primarily in injectable drug delivery device combination products.

Mike’s interest in joining Kindeva is well timed as Kindeva’s business development team has been aggressively growing our pipeline through their efforts, and our technology platforms, particularly in MTS, are rapidly maturing and gaining customer interest.

About Kindeva Drug Delivery

Headquartered in St. Paul, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microneedle transdermal systems and connected drug delivery. Kindeva employs approximately 1,000 people worldwide.